education
|
points
Download App
Malaysia
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Points
Download App
Country
Malaysia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Advertisement
Advertisement
MIMS home
Drugs
Info
Became
Became
Manufacturer:
Y.S.P. Industries
Distributor:
Y.S.P. Industries
Concise Prescribing Info
Contents
Carbinoxamine maleate 4 mg, pseudoephedrine HCl 60 mg
Indications/Uses
Symptomatic relief of seasonal & allergic rhinitis, vasomotor rhinitis.
Dosage/Direction for Use
Adult & childn > 6 yr
1 tab tds-qds,
childn 18 mth-6 yr
½ tab tds-qds.
Administration
Should be taken with food.
Contraindications
Lower resp tract disease, severe HTN, severe CAD, urinary retention, peptic ulcer, concomitant MAOI therapy. Premature infants, neonates.
Special Precautions
Hyperthyroidism, CV disease, DM, closed-angle glaucoma. Pregnancy & lactation.
Adverse Reactions
Sedation, dizziness, diplopia, vomiting, diarrhoea, dry mouth, headache, nervousness, nausea, anorexia, heartburn, polyuria, dysuria. CNS stimulation, cardiac arrhythmias, dyspnoea, tachycardia, palpitations, tremors, insomnia.
View
ADR Reporting Link
MIMS Class
Cough & Cold Preparations
/
Antihistamines & Antiallergics
ATC Classification
R01BA52 - pseudoephedrine, combinations ; Belongs to the class of systemic sympathomimetic preparations used as nasal decongestants.
Regulatory Classification
C
Presentation/Packing
Form
Became tab
Packing/Price
100 × 10's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Sign up for Free to Continue Reading
Continue with Google
Sign up with email
Already a member?
Sign in
Sign up for Free to Continue Reading
Continue with Google
Sign up with email
Already a member?
Sign in